NY-ESO-1 expression in solid tumors predicts prognosis: A systematic review and meta-analysis

BACKGROUND: New York esophageal squamous cell carcinoma 1 (NY-ESO-1) is a member of the cancer testis antigen family. NY-ESO-1 has documented potential as an effective target for cancer immunotherapy. The prognostic value of NY-ESO-1 expression in solid tumors, however, remains controversial because...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Huiyu, Chen, Datian, Wang, Runjie, Quan, Wen, Xia, Dandan, Mei, Jie, Xu, Junying, Liu, Chaoying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890322/
https://www.ncbi.nlm.nih.gov/pubmed/31770209
http://dx.doi.org/10.1097/MD.0000000000017990

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890322/
https://www.ncbi.nlm.nih.gov/pubmed/31770209
http://dx.doi.org/10.1097/MD.0000000000017990

Ejemplares similares